Article
Nosocomial infections in an oncology intensive care unit

https://doi.org/10.1016/S0196-6553(97)90067-5Get rights and content

Abstract

Introduction: Treatment of cancer has contributed to a growing number of immunocompromised patients with life-threatening nosocomial infections (NI). High mortality with considerable cost is observed when they are admitted to the intensive care unit (ICU). Few studies on infection control and surveillance have been undertaken in this population group.

Methods: All patients treated at a six-bed medical-surgical oncology ICU for >48 hours were prospectively observed for the development of an NI and the influence of device utilization on infection rates. The analysis used the standard definitions of the National Nosocomial Infection Surveillance System Intensive Care Unit surveillance component.

Results: From September 1993 through November 1995, 370 infections occurred in 623 patients during 4034 patient-days, for an overall rate of 50.0 per 100 patients or 91.7 per 1000 patient-days. Pneumonia (28.9%), urinary tract infections (25.6%), and bloodstream infections (24.1%) were the main types of infection. The most common microorganisms isolated were Enterobacteriaceae (29.7%), fungi (22.2%), and Pseudomonas aeruginosa (13.2%). The median device utilization ratios were 0.63, 0.83, and 0.86 for ventilator, indwelling urinary catheter, and central venous catheter, respectively. The highest median device-specific associated infection rate was 41.7 for ventilator. The median for the average length of stay was 8.8 days, and the average severity of illness score was 4.0. There was a strong positive correlation between the overall NI patient rate and device utilization (r = 0.56, p < 0.01), average severity of illness score (r = 0.54, p < 0.01), and average length of stay (r = 0.67, p < 0.01). No correlations were statistically significant when patient-days were used in the denominator. Among the devices only the number of central venous catheter days was significantly correlated with infections (r = 0.51, p = 0.01). The NI patient-day rates were progressively higher the longer the patients stayed in the ICU.

Conclusions: The high rates reported in this study may reflect a combination of several factors related to the underlying illness, neutrophil count, and exposure to invasive procedures. The adjusted infection rates described here provide specific surveillance data for further interhospital comparisons and also to assess the influence of invasive medical interventions, allowing the implementation of preventable measures to control infections.

References (19)

There are more references available in the full text version of this article.

Cited by (53)

  • Nosocomial infections and resistance pattern of common bacterial isolates in an intensive care unit of a tertiary hospital in Nigeria: A 4-year review

    2016, Journal of Critical Care
    Citation Excerpt :

    The few number of VAP cases is not unexpected considering the challenges of making the diagnosis especially in resource-limited settings. Nevertheless, the VAP rate among mechanically ventilated patients in this study is within the range of 10% to 41.7% reported in previous study in developing countries [18–21]. Gram-negative bacilli have been commonly associated with NI in ICU [22–24].

  • Ventilator-associated pneumonia in adults in developing countries: a systematic review

    2008, International Journal of Infectious Diseases
    Citation Excerpt :

    There were international studies that included developed and developing countries but reported pooled mean and not individual country rates.6 The VAP rate (per 1000 ventilator-days) ranged from as low as 10 per 1000 ventilator-days in Thailand25,26 and Colombia28 to a high of 41.7 per 1000 ventilator-days in a study on oncology ICU patients from Brazil.17 Figure 1 shows the VAP rates in medical-surgical ICUs compared with the pooled mean rate and 25–75 percentile rates of VAP in the US medical-surgical ICUs as per the CDC NHSN.15

  • Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis

    2011, The Lancet
    Citation Excerpt :

    Similarly, the proportion of infected patients was higher in high-quality than low-quality studies (13·5 vs 7·2 per 100 patients; p=0·0007). Overall health-care-associated infection and device-associated infection densities in adult high-risk patients were reported in 38 studies.60–97 Density of overall health-care-associated infection ranged from 9·0 to 91·7 episodes per 1000 patient-days.

  • Lower respiratory tract infections

    2022, Diagnostic Microbiology of the Immunocompromised Host
View all citing articles on Scopus
View full text